FARBER DISEASE
◊ Farber disease and SMA-PME disease ◊ Enzyme replacement therapy |
Familial combined hyperlipidaema
◊FH ◊ FALS and copper FANCONI ANEMIE ◊ Origins of re-entry and ectopic foci in the atria |
FIBROTIC SKELETAL MUSCLE
◊ Reconstruction of fibrotic skeletal muscle extracellular matrix ◊ Fragile X Syndrome Is Alleviated by Brd4 Inhibition ◊ Loss of fragile X protein FMRP impairs homeostatic synaptic downscaling through tumor suppressor p53 and ubiquitin E3 ligase Nedd4-2 ◊ Drosophila ◊ Mouse • Role of glutamate signalling (mGluRs) |